Cargando…

Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer

INTRODUCTION: Bcl-2 antanogene-1 (Bag-1) binds the anti-apoptotic mediator Bcl-2, and enhances its activity. Bcl-2 and Bag-1 are associated with chemotherapy resistance in cancer cells. Drugs that target Bcl-2 are currently in clinical development. The purpose of the present study was to examine exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nadler, Yasmine, Camp, Robert L, Giltnane, Jennifer M, Moeder, Christopher, Rimm, David L, Kluger, Harriet M, Kluger, Yuval
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397537/ https://www.ncbi.nlm.nih.gov/pubmed/18430249 http://dx.doi.org/10.1186/bcr1998

Ejemplares similares

Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models
por: Parisi, Fabio, et al.
Publicado: (2010)

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma
por: Giesen, Eva, et al.
Publicado: (2014)

Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors
por: Aziz, Saadia A, et al.
Publicado: (2013)

Characterizing disease states from topological properties of transcriptional regulatory networks
por: Tuck, David P, et al.
Publicado: (2006)

SIMVI reveals intrinsic and spatial-induced states in spatial omics data
por: Dong, Mingze, et al.
Publicado: (2023)

Impact of healthcare worker shift scheduling on workforce preservation during the COVID-19 pandemic
por: Kluger, Dan M., et al.
Publicado: (2020)

The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization
por: Kluger, Harriet M, et al.
Publicado: (2007)

Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy
por: Martinez-Morilla, Sandra, et al.
Publicado: (2020)

MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors
por: Shuch, Brian, et al.
Publicado: (2015)

Models that combine transcriptomic with spatial protein information exceed the predictive value for either single modality
por: Vathiotis, Ioannis A., et al.
Publicado: (2021)

Prognostic value of bcl-2 expression in invasive breast cancer.
por: Hellemans, P., et al.
Publicado: (1995)

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance
por: Schoenfeld, David A., et al.
Publicado: (2022)

Prognostic Value of SGK1 and Bcl-2 in Invasive Breast Cancer
por: Al-Alem, Umaima, et al.
Publicado: (2023)

Prognostic Value of BCL2 in Women Patients with Invasive Breast Cancer
por: Ayadi, E-Z, et al.
Publicado: (2018)

Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma
por: Wong, Pok Fai, et al.
Publicado: (2019)

Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells
por: Zito, Christopher R., et al.
Publicado: (2012)

Zero-preserving imputation of single-cell RNA-seq data
por: Linderman, George C., et al.
Publicado: (2022)

Vascularity of primary and metastatic renal cell carcinoma specimens
por: Aziz, Saadia A, et al.
Publicado: (2013)

The ERα coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium
por: Rokicki, Jerzy, et al.
Publicado: (2010)

Prognostic Value of Mitotic Index and Bcl2 Expression in Male Breast Cancer
por: Lacle, Miangela M., et al.
Publicado: (2013)

Targeting Innate Immunity to Treat Cancer
por: Austin, Matthew, et al.
Publicado: (2020)

Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure
por: Qu, Rihao, et al.
Publicado: (2022)

Systemic Immunotherapy for the Treatment of Brain Metastases
por: Cohen, Justine V., et al.
Publicado: (2016)

Origin and Evolution of the Human Bcl2-Associated Athanogene-1 (BAG-1)
por: Nguyen, Peter, et al.
Publicado: (2020)

Unraveling condition specific gene transcriptional regulatory networks in Saccharomyces cerevisiae
por: Kim, Hyunsoo, et al.
Publicado: (2006)

VDA, a Method of Choosing a Better Algorithm with Fewer Validations
por: Strino, Francesco, et al.
Publicado: (2011)

Regulation of Parkin-dependent mitophagy by Bcl-2-associated athanogene (BAG) family members
por: Kapadia, Minesh, et al.
Publicado: (2020)

Integrated Analysis of Tumor Samples Sheds Light on Tumor Heterogeneity
por: Parisi, Fabio, et al.
Publicado: (2012)

Drug targets and predictive biomarkers in the management of metastatic melanoma
por: Thumar, Jaykumar, et al.
Publicado: (2012)

Anti-PD-1 Therapy-Associated Perforating Colitis
por: Celli, Romulo, et al.
Publicado: (2018)

Agonistic CD40 Antibodies in Cancer Treatment
por: Djureinovic, Dijana, et al.
Publicado: (2021)

Regulation of osteoblast development by Bcl-2-associated athanogene-1 (BAG-1)
por: Greenhough, Joanna, et al.
Publicado: (2016)

Diagnostic and prognostic value of Bcl-2 in uterine leiomyosarcoma
por: Travaglino, Antonio, et al.
Publicado: (2022)

Bcl-2-associated athanogene 5 (BAG5) regulates Parkin-dependent mitophagy and cell death
por: De Snoo, Mitchell L., et al.
Publicado: (2019)

Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts
por: Baquero, Maria T, et al.
Publicado: (2011)

Inter- and intra-combinatorial regulation by transcription factors and microRNAs
por: Zhou, Yiming, et al.
Publicado: (2007)

Relationship between gene co-expression and probe localization on microarray slides
por: Kluger, Yuval, et al.
Publicado: (2003)

TrAp: a tree approach for fingerprinting subclonal tumor composition
por: Strino, Francesco, et al.
Publicado: (2013)

Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer
por: Elfiky, Aymen A, et al.
Publicado: (2011)

Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
por: Aziz, Saadia A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l080b6ag6kmidcimdcqgdigh36